Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In another phase I trial of CB-839 and paclitaxel in triple negative breast cancer, patients receiving CB-839 and paclitaxel showed different extents of improvement from disease control to partial response with tolerable adverse effects [64]
Insulin/IGF-1/FoxO signaling and cancer GH, IGF-1 and insulin have cancer-promoting actions and raised serum IGF-1 levels have been associated with increased risk of prostate, breast and colorectal cancers [13]
Touching vial tops with bare hands introduces bacteria
You will receive the exact brand that you request
US$ 24.40
US$ 27.17
US$ 29.48
